Quantcast

Latest Americord Stories

2014-09-22 08:29:37

Research explores the benefits of using autologous cord blood stem cells for children with Cerebral Palsy NEW YORK, Sept. 22, 2014 /PRNewswire/ -- Americord announced today that it has provided funding to support a clinical trial investigating the efficacy of autologous umbilical cord blood for the treatment of pediatric patients with cerebral palsy. Logo - http://photos.prnewswire.com/prnh/20140919/147316 This trial is being conducted under the direction of an internationally...

2014-07-15 12:28:51

Hoskins Joins Leading Doctors to Help Guide Americord's Innovations in Cord Blood Banking NEW YORK, July 15, 2014 /PRNewswire/ -- Americord announced today that Iffath Abbasi Hoskins, M.D. has joined the company's Advisory Board. Dr. Hoskins is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at NYU Langone Medical Center in New York City. She is a practicing obstetrician-gynecologist and a sub-specialist in maternal-fetal medicine, which focuses on...

2014-06-11 12:28:59

Americord's Significant Investment in Brooklyn Will Create New Jobs in New York NEW YORK, June 11, 2014 /PRNewswire/ -- Americord announced today that it will expand its presence in New York as a result of START-UP NY, an initiative that creates tax-free areas across New York State. Under the program, Americord will invest more than $402,000 toward a new research and development laboratory and spur the creation of new jobs. "We are thrilled to be among the first companies to take...

2014-05-27 12:33:02

Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors NEW YORK, May 27, 2014 /PRNewswire/ -- Americord announced today that its cord blood stem cell collection statistics beat the cord blood banking industry averages by significant margins across three critical measures. An in-depth analysis of collection samples through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total...

2014-05-16 12:27:11

Abstract Presented at ASPHO Conference by Americord's Medical Director Dr. Robert Dracker NEW YORK, May 16, 2014 /PRNewswire/ -- Breakthrough technology that harvests stem cells from the placenta was presented in an abstract written by Dr. Robert A. Dracker, Americord's Executive Medical Director, at the 27(th) annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO). The new stem cell harvesting technology enables parents to collect as many as twice the...

2014-05-05 12:28:28

Funds Will Support Research Into Safety and Efficacy of NEUROSTEM-AD® NEW YORK, May 5, 2014 /PRNewswire/ -- Americord announced today that it has provided funding to MEDIPOST, a leading stem cell biotechnology company, to support their clinical trial investigating the use of NEUROSTEM-AD® in the treatment of patients with Alzheimer's Disease. NEUROSTEM-AD® is a treatment agent for Alzheimer's Disease that uses human umbilical cord blood-derived mesenchymal stem cells. This is the...

2014-04-28 12:27:26

Americord CEO Interviewed For Article Exploring Good And Bad Practices In The Industry NEW YORK, April 28, 2014 /PRNewswire/ -- Americord Registry client Whitney Ferrarese was featured in an extensive front page Wall Street Journal article published last week about her family's positive experience with cord blood banking. Ms. Ferrarese and her husband chose Americord to store their first baby's cord blood after a long online search, and they plan to store their second baby's cord...

2014-04-14 16:25:26

Americord Raises Standards of Customer Service in Cord Blood Industry NEW YORK, April 14, 2014 /PRNewswire/ -- Cord Blood Banking leader Americord today published a bill of rights it believes every cord blood banking client should expect to receive from their cord blood bank. Encompassing information as well as service, the "Cord Blood Banking Bill of Rights" covers fundamental issues such as transparency and equitable pricing and ensures that clients who are storing their cord...

2014-04-08 12:31:24

Funds Will Support the Advancement of Cutting Edge Stem Cell Research Worldwide NEW YORK, April 8, 2014 /PRNewswire/ -- Americord announced today the launch of its corporate giving program, which will support research focused on the therapeutic uses of stem cells from umbilical cord blood, cord tissue and placenta tissue. In addition to ongoing and future clinical trials focused on a broad array of diseases, conditions, and injuries, Americord's corporate giving program may also fund...

2014-03-24 12:29:54

Americord's Quality Guarantee Remains the Highest in the Industry, Topping Cord Blood Stem Cell Banks ViaCord and CBR NEW YORK, March 24, 2014 /PRNewswire/ -- Today, less than two years after Americord implemented the highest ever quality guarantee in the cord blood banking industry at $80,000, the company has announced that it is increasing its guarantee to $90,000. Like other leading cord blood banks, Americord offers a quality guarantee to provide financial assistance to clients...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.